tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:3692 Stock Latest News

Hansoh Pharma Wins NMPA Review Nod for New Targeted Lung Cancer Therapy
Company AnnouncementsHansoh Pharma Wins NMPA Review Nod for New Targeted Lung Cancer Therapy
2h ago
3692
Hansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib
PremiumCompany Announcements
Hansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib
8d ago
3692
Hansoh Pharmaceutical Raises HK$4.68 Billion via Zero-Coupon Convertible Bonds to Fuel Drug R&D
PremiumCompany Announcements
Hansoh Pharmaceutical Raises HK$4.68 Billion via Zero-Coupon Convertible Bonds to Fuel Drug R&D
24d ago
3692
Hansoh Pharmaceutical to Raise HK$4.68 Billion via Zero-Coupon Convertible Bonds
PremiumCompany Announcements
Hansoh Pharmaceutical to Raise HK$4.68 Billion via Zero-Coupon Convertible Bonds
1M ago
3692
Hansoh Pharma Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile
PremiumCompany Announcements
Hansoh Pharma Wins Fifth China Approval for Flagship Lung Cancer Drug Ameile
2M ago
3692
Hansoh Pharma Licenses Hengrui’s Late-Stage Kidney Drug SHR6508 for China
PremiumCompany AnnouncementsHansoh Pharma Licenses Hengrui’s Late-Stage Kidney Drug SHR6508 for China
2M ago
3692
Hansoh Pharma Adds Veteran Lawyer Yan Jia to Board, Bolsters Governance Committees
Premium
Company Announcements
Hansoh Pharma Adds Veteran Lawyer Yan Jia to Board, Bolsters Governance Committees
2M ago
3692
Hansoh Pharmaceutical Details Board Composition and Committee Roles
Premium
Company Announcements
Hansoh Pharmaceutical Details Board Composition and Committee Roles
2M ago
3692
Hansoh Pharma Enters Global Licensing Agreement with Glenmark for Aumolertinib
PremiumCompany Announcements
Hansoh Pharma Enters Global Licensing Agreement with Glenmark for Aumolertinib
2M ago
3692
Hansoh Pharmaceutical Advances with New Drug Inclusions in 2025 NRDL
PremiumCompany Announcements
Hansoh Pharmaceutical Advances with New Drug Inclusions in 2025 NRDL
3M ago
3692
Hansoh Pharmaceutical’s New Drug Application for Lung Cancer Treatment Accepted
PremiumCompany Announcements
Hansoh Pharmaceutical’s New Drug Application for Lung Cancer Treatment Accepted
4M ago
3692
Hansoh Pharmaceutical Partners with Roche for Global Cancer Drug Development
PremiumCompany Announcements
Hansoh Pharmaceutical Partners with Roche for Global Cancer Drug Development
4M ago
3692
Hansoh Pharmaceutical Announces Interim Dividend for 2025
PremiumCompany AnnouncementsHansoh Pharmaceutical Announces Interim Dividend for 2025
5M ago
3692
Hansoh Pharmaceutical Adjusts Interim Dividend Dates Due to Weather
Premium
Company Announcements
Hansoh Pharmaceutical Adjusts Interim Dividend Dates Due to Weather
5M ago
3692
Hansoh Pharmaceutical’s XINYUE Gains Second Indication Approval in China
Premium
Company Announcements
Hansoh Pharmaceutical’s XINYUE Gains Second Indication Approval in China
6M ago
3692
Hansoh Pharmaceutical Announces New Share Placement to Raise HK$3.9 Billion
PremiumCompany Announcements
Hansoh Pharmaceutical Announces New Share Placement to Raise HK$3.9 Billion
6M ago
3692
Hansoh Pharmaceutical Declares Interim Dividend for H1 2025
PremiumCompany Announcements
Hansoh Pharmaceutical Declares Interim Dividend for H1 2025
6M ago
3692
Hansoh Pharmaceutical Reports Strong Growth and Key Drug Approvals in H1 2025
PremiumCompany Announcements
Hansoh Pharmaceutical Reports Strong Growth and Key Drug Approvals in H1 2025
6M ago
3692
Hansoh Pharmaceutical Schedules Board Meeting for Interim Results
PremiumCompany Announcements
Hansoh Pharmaceutical Schedules Board Meeting for Interim Results
7M ago
3692
Hansoh Pharmaceutical Successfully Concludes AGM with Key Resolutions Passed
PremiumCompany AnnouncementsHansoh Pharmaceutical Successfully Concludes AGM with Key Resolutions Passed
8M ago
3692
Hansoh Pharmaceutical’s Aumolertinib Mesilate Tablets Approved for UK Market
Premium
Company Announcements
Hansoh Pharmaceutical’s Aumolertinib Mesilate Tablets Approved for UK Market
9M ago
3692
Hansoh Pharmaceutical Enters Strategic License Agreement with Regeneron
Premium
Company Announcements
Hansoh Pharmaceutical Enters Strategic License Agreement with Regeneron
9M ago
3692

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >